Literature DB >> 3085103

A DNA insertion/deletion necessitates an aberrant RNA splice accounting for a mu heavy chain disease protein.

A Bakhshi, P Guglielmi, U Siebenlist, J V Ravetch, J P Jensen, S J Korsmeyer.   

Abstract

The human heavy chain disease protein BW is an immunoglobulin mu-chain variant whose amino terminus is initiated at the fifth amino acid of the first constant region domain. We cloned and analyzed both rearranged heavy chain alleles from BW leukemic cells to determine the molecular basis for this deleted protein. The phenotypically excluded heavy-chain allele possessed two intermediate recombinations of separate variable-diversity (V-D) and diversity-joining (D-J) junctions, neither of which were expressed. The productive allele, responsible for the mu chain, had a complete V-D-J4 recombination but as a result of a single-base deletion possessed stop codons within the variable region. More important, a small DNA insertion/deletion eliminated the J4 donor splice site. This necessitated an aberrant RNA splice between the leader region and the first constant region domain creating a shortened 2.35-kilobase muRNA. A recognition sequence for signal peptidase predicted a cleavage at the fifth amino acid of the first constant region domain. These molecular events are responsible for the truncated mu chain that lacks a variable region and fails to assemble light chains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085103      PMCID: PMC323365          DOI: 10.1073/pnas.83.8.2689

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Heavy chain diseases: current findings and concepts.

Authors:  M Seligmann; E Mihaesco; J L Preud'homme; F Danon; J C Brouet
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Gel electrophoresis of restriction fragments.

Authors:  E Southern
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  The defect in mu heavy chain disease protein GLI.

Authors:  E C Franklin; B Frangione; F Prelli
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

5.  Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways.

Authors:  P Early; J Rogers; M Davis; K Calame; M Bond; R Wall; L Hood
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

6.  A mutant immunoglobulin light chain is formed by aberrant DNA- and RNA-splicing events.

Authors:  J G Seidman; P Leder
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

7.  RNA splicing generates a variant light chain from an aberrantly rearranged kappa gene.

Authors:  E Choi; M Kuehl; R Wall
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

8.  An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.

Authors:  P Early; H Huang; M Davis; K Calame; L Hood
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

9.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  14 in total

1.  Effect of 5' splice site mutations on splicing of the preceding intron.

Authors:  M Talerico; S M Berget
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit.

Authors:  D A Sterner; S M Berget
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

3.  Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease.

Authors:  T Goossens; U Klein; R Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production.

Authors:  T Komori; H Sugiyama
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

5.  Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation.

Authors:  Xinjun Zhang; Hai Lin; Huiying Zhao; Yangyang Hao; Matthew Mort; David N Cooper; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

Review 6.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

7.  Nucleotide sequence of an unequal sister chromatid exchange site in a mouse myeloma cell line.

Authors:  D R Katzenberg; S A Tilley; B K Birshtein
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

8.  Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene.

Authors:  A Alexander; I Anicito; J Buxbaum
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene.

Authors:  H Steingrimsdottir; G Rowley; G Dorado; J Cole; A R Lehmann
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

10.  Single base mutation in the pro alpha 2(I) collagen gene that causes efficient splicing of RNA from exon 27 to exon 29 and synthesis of a shortened but in-frame pro alpha 2(I) chain.

Authors:  G Tromp; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.